OPG (Osteoprotegerin) as a biomarker of Coronary Artery Disease
El sayed Soliman, S., Sabbah, N., Elsanan, M., Abd elnour, H. (2023). OPG (Osteoprotegerin) as a biomarker of Coronary Artery Disease. EKB Journal Management System, (), -. doi: 10.21608/zumj.2023.245649.2990
Shrook Muhammed El sayed Soliman; Norhan Abdallah Sabbah; Moataz Elsanan; Hanim Magdy Abd elnour. "OPG (Osteoprotegerin) as a biomarker of Coronary Artery Disease". EKB Journal Management System, , , 2023, -. doi: 10.21608/zumj.2023.245649.2990
El sayed Soliman, S., Sabbah, N., Elsanan, M., Abd elnour, H. (2023). 'OPG (Osteoprotegerin) as a biomarker of Coronary Artery Disease', EKB Journal Management System, (), pp. -. doi: 10.21608/zumj.2023.245649.2990
El sayed Soliman, S., Sabbah, N., Elsanan, M., Abd elnour, H. OPG (Osteoprotegerin) as a biomarker of Coronary Artery Disease. EKB Journal Management System, 2023; (): -. doi: 10.21608/zumj.2023.245649.2990

OPG (Osteoprotegerin) as a biomarker of Coronary Artery Disease

Zagazig University Medical Journal
Articles in Press, Accepted Manuscript, Available Online from 31 October 2023  XML
Document Type: Review Articles
DOI: 10.21608/zumj.2023.245649.2990
View on SCiNiTO View on SCiNiTO
Authors
Shrook Muhammed El sayed Soliman email 1; Norhan Abdallah Sabbah2; Moataz Elsanan3; Hanim Magdy Abd elnour4
1Demonstrator of Medical Biochemistry, Faculty of Medicine , Zagazig University.
2Department of Biochemistry, Faculty of Medicine – Zagazig University, Egypt
3Lecturer of cardiology -faculty of medicine
4medical biochmestry and molecular biology department, faculty of medicine, Zagazig univerisity, Zagazig, Egypt
Abstract
Coronary artery disease (CAD), including its most severe complication, myocardial infarction (MI), is the leading cause of death in the industrialized world. As the most serious clinical manifestation of CAD, MI is the condition of irreversible necrosis of the heart muscle that results from prolonged ischemia. Approximately 90 % of MI results from the formation of an acute thrombus that obstructs an atherosclerotic coronary artery. Coronary artery disease (CAD) is a major cause of mortality and morbidity in the general population worldwide. CAD has a complex etiopathogenesis and a multifactorial origin. Osteoprotegerin (OPG) that is a glycoprotein belonging to the tumor necrosis factor (TNF) receptor superfamily, functions as a dummy receptor for both the TNF-linked apoptosis-inducing ligand (TRAIL) and the nuclear factor κ-B ligand receptor (RANKL). These elevated OPG levels are linked to a wider variety of coronary artery atherosclerotic lesions and an increased mortality risk. The relationship between serum OPG (osteoprotegerin) level with the development and progression of CAD among patients is not clear. It may be potential predictor of CAD among patients and may be used in the treatment of CAD.
Keywords
CAD; OPG; MI
Statistics
Article View: 45